What is the EPS of Haleos Labs Limited?

Haleos Labs Limited has an earnings per share (EPS) of ₹52.45 for the latest trailing twelve months (TTM).

What are the P/E and P/B ratios of Haleos Labs Limited?

As of 27 Aug 2026, Haleos Labs Limited has a P/E ratio of 18.69 and a P/B ratio of 1.90.

What are the ROE and ROCE of HALEOSLABS?

HALEOSLABS reported an ROE of 8.28% and an ROCE of 10.09%.

What are the dividend yield and book value of Haleos Labs Limited?

As of 27 Aug 2026, Haleos Labs Limited has a dividend yield of 0.10% and a book value of ₹709.74 per share.

What are the profit margin and operating margin of HALEOSLABS?

HALEOSLABS reported a net profit margin of 5.47% and an operating profit margin of 9.38%.

How has HALEOSLABS's revenue changed over the last 1, 3, and 5 years?

HALEOSLABS's revenue has changed by -10.35% over the last 1 year, -4.94% over the last 3 years, and -12.89% over the last 5 years.

Haleos Labs Limited Fundamental Analysis

Pharmaceuticals Small Cap

Last Updated Date: 27 Aug 2026

₹1,497.50

-52.50 (-3.39%)

Haleos Labs Limited (Haleos Labs Limited) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹453 crore.

Haleos Labs Limited Overview

Market cap₹453 Crs

Volume37

Prev. Close₹1,550.00

Year range₹1,084.15 - ₹1,778.35

Total Value₹55,407.50

ISININE320X01016